Retractable Technologies (NYSE:RVP) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Retractable Technologies (NYSE:RVP) in a research note released on Wednesday. The brokerage issued a hold rating on the stock.

Retractable Technologies Stock Performance

NYSE RVP opened at $0.62 on Wednesday. The firm’s fifty day moving average price is $0.71 and its two-hundred day moving average price is $0.93. The stock has a market cap of $18.56 million, a PE ratio of -1.15 and a beta of 2.06. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.92 and a current ratio of 8.57. Retractable Technologies has a fifty-two week low of $0.56 and a fifty-two week high of $1.34.

Insider Activity

In related news, CEO Thomas J. Shaw bought 71,422 shares of Retractable Technologies stock in a transaction that occurred on Friday, September 20th. The shares were acquired at an average cost of $0.82 per share, for a total transaction of $58,566.04. Following the completion of the acquisition, the chief executive officer now directly owns 14,743,907 shares of the company’s stock, valued at approximately $12,090,003.74. The trade was a 0.49 % increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. Over the last 90 days, insiders acquired 179,515 shares of company stock valued at $143,037. Insiders own 55.00% of the company’s stock.

Hedge Funds Weigh In On Retractable Technologies

A hedge fund recently bought a new stake in Retractable Technologies stock. PFG Investments LLC acquired a new stake in Retractable Technologies, Inc. (NYSE:RVP) during the third quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned 0.12% of Retractable Technologies at the end of the most recent reporting period. 7.58% of the stock is owned by institutional investors.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.